A variety of cancers display constitutive PD-L1 expression, which can be triggered by genetic and epigenetic alterations in its promoter region, cytokine stimulation, such as IFN-γ and IL-6, growth factors, hypoxia, among others (28). Here, IFNG is linked to cancer.